Neumora Therapeutics, Inc.'s total assets for Q1 2026 were $153.88M, a decrease of -19.46% from the previous quarter. NMRA total liabilities were $83.20M for the fiscal quarter, a -4.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.